What Are The Ramifications of Suboptimal Medication Adherence?

Zonana: There are several ramifications depending on who you’re speaking with. Particularly, in some therapy classes, depending on the pharmacokinetic profile of the medication, suboptimal adherence may result in drug resistance, which may lead to another therapy being prescribed. In other cases, it may lead to a hospital admission or readmission or an emergency department visit.
In other categories, like in treatment for addiction, it might lead to relapse. So, it costs the system significant dollars and it costs pharmaceutical companies in the way of low persistency curves or suboptimal persistency in adherence that might not lead to the efficacy results that the therapy first advertised after clinical trials. 

Most Popular

Related Articles

Study suggests that covering high-value medications benefits patients at no extra cost to insurers.
Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Excelera has announced the appointment of Lorrie A. Carr as its new CEO. Ms. Carr succeeds Jim Fox who retired effective April 2.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.